niflumic acid has been researched along with Osteosarcoma in 1 studies
Niflumic Acid: An analgesic and anti-inflammatory agent used in the treatment of rheumatoid arthritis.
Osteosarcoma: A sarcoma originating in bone-forming cells, affecting the ends of long bones. It is the most common and most malignant of sarcomas of the bones, and occurs chiefly among 10- to 25-year-old youths. (From Stedman, 25th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Liao, WC | 1 |
| Chou, CT | 1 |
| Liang, WZ | 1 |
| Hao, LJ | 1 |
| Kuo, CC | 1 |
| Lin, KL | 1 |
| Wang, JL | 1 |
| Jan, CR | 1 |
1 other study available for niflumic acid and Osteosarcoma
| Article | Year |
|---|---|
Exploration of Niflumic Acid’s Action on Ca²⁺ Movement and Cell Viability in Human Osteosarcoma Cells.
Topics: Apoptosis; Bone Neoplasms; Calcium; Calcium Signaling; Cell Line, Tumor; Cell Survival; Humans; Nifl | 2018 |